The use of cultured hepatocytes to investigate the mechanisms of drug hepatotoxicity

Cell Biology and Toxicology

Volumn 13, Issue 4-5, 1997, Pages 331-338

  Castell, J V ^a   Gomez Lechon M J ^a   Ponsoda, X ^a   Bort, R ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Calcium homeostasis; Covalent binding; Diclofenac; Human hepatocytes; Lipid peroxidation; Oxidative stress; Rat hepatocytes

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALBUMIN; DICLOFENAC;

ANIMAL CELL; CALCIUM HOMEOSTASIS; CELL DEATH; CELL LINE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DEFENSE MECHANISM; DRUG SCREENING; DRUG TRANSFORMATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER CELL CULTURE; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; DICLOFENAC; HUMANS; LIVER; TOXICITY TESTS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030875708     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007443610025     Document Type: Conference Paper

References (30)

1. Boelsterli UA. Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury. Drug Metab Rev. 1993;25:395-451.
2. Boobis AR, Duncan J, Fawthrop J, Davies DS. Mechanisms of cell death. Trends Pharm Sci. 1989;10:275-80.
3. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987;47:936-42.
4. Castell JV, Gómez-Lechón MJ. In vitro investigation of the molecular mechanisms of hepatotoxicity. In: Castell JV, Gómez-Lechón MJ, eds. In vitro methods in pharmaceutical research. London: Academic Press; 1996:375-410.
5. Castell JV, Montoya A, Larrauri A, López P, Gómez-Lechón MJ. Effects of benorylate and impacine on the metabolism of cultured hepatocytes. Xenobiotica. 1985;15:743-9.
6. Clapham DE. Calcium signaling. Cell. 1995;80:259-68.
7. Columbano A. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem. 1995;58:181-90.
8. Duverger-van Bogaert M, Wiame D, Stecca C. Oxidative activation of 2-aminofluorene by human red blood cell cytosol. Biochem Pharmacol. 1992;44:2422-4.
9. Eriksson UG, Brasch RC, Tozer TN Nonenzymatic bioreduction in rat liver and kidney of nitroxyl spin labels, potential contrast agents in magnetic resonance imaging. Drug Metab Dispos. 1987;15:155-60.
10. Gómez-Lechón MJ, Donate T, Ponsoda X, Fabra R, Trullenque R, Castella JV. Isolation, culture and use of human hepatocytes in drug research. In: Castell JV, Gómez-Lechón MJ, eds. In vitro methods in pharmaceutical research. London: Academic Press; 1996:129-54.
11. Hinson JA, Roberts DW. Role of covalent and noncovalent interactions in cell toxicity: effects on proteins. Annu Rev Pharmacol Toxicol. 1992;32:471-510.
12. Kappus H. Overview of enzyme systems involved in bioreduction of drugs and redox cycling. Biochem Pharmacol. 1986;35:1-6.
13. Lindeke B. The non- and postenzymatic chemistry of N-oxygenated molecules. Drug Metab Rev. 1982;23:253-309.
14. Loeper J, Descatoire V, Maurice M et al. Cytochrome P450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology. 1993;104:203-16.
15. Nieminen AL, Saylor AK, Tesfai SA, Herman B, Lemasters JJ. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J. 1995;307:99-106.
16. Poli G, Albano E, Dianzani MU. The role of lipid peroxidation in liver damage. Chem Phys Lipids. 1987;45:117-42.
17. Ponsoda X, Bort R, Jover R, Gómez-Lechón MJ, Castell JV. Molecular mechanisms of diclofenac hepatotoxicity: cell injury is associated to the metabolism of the drug and is precluded by a decrease in ATP levels. Toxicol In Vitro. 1995;9:439-44.
18. Reed JD. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol. 1990;30:603-31.
19. Robin MA, Maratrat M, Loeper J et al Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology. 1995;108:1110-23.
20. Rosen GM, Ranckman EJ, Hauck KW. Selective bioreduction of nitroxides by rat liver microsomes. Toxicol Lett. 1977;1: 71-4.
21. Ross D. Mechanistic toxicology: a radical perspective. J Pharm Pharmacol. 1989;41:505-11.
22. Rosser BG, Gores GJ. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology. 1995;108:252-75.
23. Scully LJ, Clarke D, Barr RJ. Diclofenac induced hepatitis: three cases with features of autoimmune chronic active hepatitis. Dig Dis Sci. 1993;38:744-51.
24. 2+-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol Appl Pharmacol. 1992;112:32-40.
25. Sies H. Oxidative stress: Introduction. In: Sies H, ed. Oxidative stress. Oxidants and antioxidants. London: Academic Press; 1971:xv-xxii.
26. Swartz MN. Mitochondrial toxicity: new adverse drug effects. N Engl J Med. 1995;333:1146-8.
27. Testa B. The metabolism of drugs and other xenobiotics. In: Testa B, Caldwell J, eds. Biochemistry of redox reductions. London: Academic Press; 1995a:164-84.
28. Testa B. The metabolism of drugs and other xenobiotics. In: Testa B, Caldwell J, eds. Biochemistry of redox reductions. London: Academic Press; 1995b:424-6.
29. Yamada H, Babat T, Oguri K, Yoshimura H. Enzymatic reduction of N-hydroxyamphetamine: the role of electron transfer system containing cytochrome b5. Biochem Pharmacol. 1988;37:368-73.
30. Zimmerman HJ, Ishak KG. General aspects of drug-induced liver diseases. Gastroenterol Clin North Am. 1995;24:739-58.